Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy
Clinical trial NCT06449209 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06449209
- Sponsor
- BioNTech SE
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-05
- Primary completion
- 2027-06-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.